Annual Non Current Assets
$250.78 M
+$195.96 M+357.44%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual long term assets is currently $250.78 million, with the most recent change of +$195.96 million (+357.44%) on 31 December 2023. During the last 3 years, it has risen by +$217.68 million (+657.43%). CPRX annual non current assets is now at all-time high.CPRX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$233.01 M
+$1.08 M+0.47%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly long term assets is currently $233.01 million, with the most recent change of +$1.08 million (+0.47%) on 30 September 2024. Over the past year, it has increased by +$11.82 million (+5.34%). CPRX quarterly non current assets is now -7.09% below its all-time high of $250.78 million, reached on 31 December 2023.CPRX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +357.4% | +5.3% |
| 3 y3 years | +657.4% | +665.1% |
| 5 y5 years | +4665.4% | +3712.9% |
CPRX Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +806.0% | -7.1% | +841.4% |
| 5 y | 5 years | at high | >+9999.0% | -7.1% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -7.1% | >+9999.0% |
Catalyst Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $233.01 M(+0.5%) |
| June 2024 | - | $231.93 M(-4.2%) |
| Mar 2024 | - | $242.07 M(-3.5%) |
| Dec 2023 | $219.33 M(-31.6%) | $250.78 M(+13.4%) |
| Sept 2023 | - | $221.19 M(+9.0%) |
| June 2023 | - | $202.93 M(-2.6%) |
| Mar 2023 | - | $208.32 M(+280.0%) |
| Dec 2022 | $320.81 M(+52.7%) | $54.82 M(-3.5%) |
| Sept 2022 | - | $56.80 M(+129.5%) |
| June 2022 | - | $24.75 M(-4.0%) |
| Mar 2022 | - | $25.78 M(-6.9%) |
| Dec 2021 | $210.11 M(+31.9%) | $27.68 M(-9.1%) |
| Sept 2021 | - | $30.45 M(-7.2%) |
| June 2021 | - | $32.83 M(-8.0%) |
| Mar 2021 | - | $35.68 M(+7.8%) |
| Dec 2020 | $159.24 M(+43.0%) | $33.11 M(+5.1%) |
| Sept 2020 | - | $31.52 M(>+9900.0%) |
| June 2020 | - | $248.10 K(-73.5%) |
| Mar 2020 | - | $936.10 K(-7.6%) |
| Dec 2019 | $111.36 M(+101.8%) | $1.01 M(-83.4%) |
| Sept 2019 | - | $6.11 M(-1.1%) |
| June 2019 | - | $6.18 M(-0.6%) |
| Mar 2019 | - | $6.21 M(+18.1%) |
| Dec 2018 | $55.19 M(-35.2%) | $5.26 M(+0.6%) |
| Sept 2018 | - | $5.23 M(+0.5%) |
| June 2018 | - | $5.20 M(+2604.8%) |
| Mar 2018 | - | $192.30 K(-4.0%) |
| Dec 2017 | $85.19 M(+105.5%) | $200.30 K(-6.5%) |
| Sept 2017 | - | $214.30 K(-5.7%) |
| June 2017 | - | $227.20 K(-5.4%) |
| Mar 2017 | - | $240.10 K(-5.1%) |
| Dec 2016 | $41.45 M(-30.8%) | $253.10 K(-1.9%) |
| Sept 2016 | - | $257.90 K(-3.6%) |
| June 2016 | - | $267.40 K(+42.8%) |
| Mar 2016 | - | $187.20 K(-6.6%) |
| Dec 2015 | $59.90 M | $200.40 K(-3.0%) |
| Sept 2015 | - | $206.50 K(+186.0%) |
| June 2015 | - | $72.20 K(-9.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $80.00 K(-0.4%) |
| Dec 2014 | $43.83 M(+73.1%) | $80.30 K(+0.1%) |
| Sept 2014 | - | $80.20 K(+7.9%) |
| June 2014 | - | $74.30 K(+20.8%) |
| Mar 2014 | - | $61.50 K(+24.2%) |
| Dec 2013 | $25.32 M(+51.4%) | $49.50 K(-10.3%) |
| Sept 2013 | - | $55.20 K(-9.4%) |
| June 2013 | - | $60.90 K(-8.6%) |
| Mar 2013 | - | $66.60 K(+6.4%) |
| Dec 2012 | $16.73 M(+168.6%) | $62.60 K(+217.8%) |
| Sept 2012 | - | $19.70 K(-12.1%) |
| June 2012 | - | $22.40 K(-3.9%) |
| Mar 2012 | - | $23.30 K(+10.4%) |
| Dec 2011 | $6.23 M(+7.8%) | $21.10 K(-26.7%) |
| Sept 2011 | - | $28.80 K(-20.4%) |
| June 2011 | - | $36.20 K(-34.8%) |
| Mar 2011 | - | $55.50 K(-1.1%) |
| Dec 2010 | $5.78 M(-26.8%) | $56.10 K(-5.9%) |
| Sept 2010 | - | $59.60 K(-9.6%) |
| June 2010 | - | $65.90 K(-8.7%) |
| Mar 2010 | - | $72.20 K(-8.6%) |
| Dec 2009 | $7.89 M(-33.8%) | $79.00 K(-5.6%) |
| Sept 2009 | - | $83.70 K(-8.0%) |
| June 2009 | - | $91.00 K(-10.2%) |
| Mar 2009 | - | $101.30 K(-14.0%) |
| Dec 2008 | $11.92 M(-27.9%) | $117.80 K(-9.4%) |
| Sept 2008 | - | $130.00 K(-5.9%) |
| June 2008 | - | $138.10 K(-5.7%) |
| Mar 2008 | - | $146.40 K(-1.2%) |
| Dec 2007 | $16.53 M(-19.7%) | $148.20 K(+1.6%) |
| Sept 2007 | - | $145.90 K(+108.7%) |
| June 2007 | - | $69.90 K(+64.1%) |
| Mar 2007 | - | $42.60 K(+34.4%) |
| Dec 2006 | $20.59 M(+2568.2%) | $31.70 K(-93.7%) |
| Sept 2006 | - | $505.30 K(+1219.3%) |
| June 2006 | - | $38.30 K(+114.0%) |
| Dec 2005 | $771.60 K(+319.6%) | $17.90 K(+1093.3%) |
| Dec 2004 | $183.90 K(+71.7%) | $1500.00 |
| Dec 2002 | $107.10 K | - |
FAQ
- What is Catalyst Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual non current assets year-on-year change?
- What is Catalyst Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly non current assets year-on-year change?
What is Catalyst Pharmaceuticals annual long term assets?
The current annual non current assets of CPRX is $250.78 M
What is the all time high annual non current assets for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual long term assets is $250.78 M
What is Catalyst Pharmaceuticals annual non current assets year-on-year change?
Over the past year, CPRX annual long term assets has changed by +$195.96 M (+357.44%)
What is Catalyst Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of CPRX is $233.01 M
What is the all time high quarterly non current assets for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly long term assets is $250.78 M
What is Catalyst Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, CPRX quarterly long term assets has changed by +$11.82 M (+5.34%)